1. Home
  2. ATEX vs DRTS Comparison

ATEX vs DRTS Comparison

Compare ATEX & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anterix Inc.

ATEX

Anterix Inc.

BUY

Current Price

$84.06

Market Cap

1.5B

ML Signal

BUY

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$14.55

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEX
DRTS
Founded
1997
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ATEX
DRTS
Price
$84.06
$14.55
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
★ $112.33
$17.80
AVG Volume (30 Days)
234.7K
★ 441.6K
Earning Date
11-11-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 891.80
N/A
EPS
★ 0.01
N/A
Revenue
★ $6,501,000.00
N/A
Revenue This Year
$220.44
N/A
Revenue Next Year
N/A
$1,235.59
P/E Ratio
$8,558.00
★ N/A
Revenue Growth
★ 7.79
N/A
52 Week Low
$17.58
$3.43
52 Week High
$113.00
$15.79

Technical Indicators

Market Signals
Indicator
ATEX
DRTS
Relative Strength Index (RSI) 49.63 48.43
Support Level $81.61 $13.73
Resistance Level $87.28 $15.01
Average True Range (ATR) 3.93 0.58
MACD 0.79 -0.09
Stochastic Oscillator 76.11 13.18

Price Performance

Historical Comparison
ATEX
DRTS

About ATEX Anterix Inc.

Anterix Inc is the holder of licensed 900 MHz spectrum (896-901/935-940 MHz) with coverage spanning the contiguous United States, Hawaii, Alaska, and Puerto Rico. The Company is focused on commercializing its spectrum assets and delivering intelligent infrastructure solutions, including private broadband networks, tower access, and turnkey connectivity management, to utility and critical infrastructure enterprises. It provides mission-critical private 900 MHz spectrum to the utility sector and integrated deployment solutions that support a secure, resilient, and decarbonized future. Its solutions include 900 MHz Private Wireless, TowerX, and CatalyX.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: